Identifying increased XPO1 expression in Solid-PCa cells of TripleTg mice and human CRPC samples in this study provided additional experimental evidence for the oncogenic role of XPO1 in advancing PCa progression, hormone refractoriness, and CRPC development, which further supports the development of the relevant therapeutic strategies for treating advanced PCa. Here, XPO1 is linked to posterior cortical atrophy.